Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV

NCT04255849 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT04255849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04255849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
Lead sponsor
Weill Medical College of Cornell University
Phase
Phase 3
Overall status
Active, not recruiting
Start date
February 23, 2021
Completion date
December 31, 2026
Enrollment
700 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection, hpv infection, hpv positive oropharyngeal squamous cell carcinoma